Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. edor box

EDOR BOX

Electrodermal Orienting Reactivity-based Safeguard System for Early Detection of Suicide Propensity

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 EDOR BOX project word cloud

Explore the words cloud of the EDOR BOX project. It provides you a very rough idea of what is the project "EDOR BOX" about.

prescribed    swedish    detect    health    billion    lack    800    tests    alarming    detected    efficacy    29    innovative    age    tool    350    diagnostic    people    brain    million    economic    creation    patients    suicide    risk    economically    onset    antidepressants    sensitivity    coming    groups    97    limitations    attempts    subjective    sweat    safety    tools    global    appallingly    absent    suicides    prevent    signals    disorder    world    attempt    audio    distinguish    impulses    incurred    save    burden    detection    revenues    15    rates    reactivity    box    applicability    society    committing    electrodermal    diagnosis    half    clinical    demonstrated    edor    solution    analyzes    alone    trials    death    jobs    actually    reflected    organization    according    population    insufficient    exposed    overcome    suicidal    ultimately    company    17    44    emotra    youngsters    expressed    yearly    prove    depression    attributed    emotionally    depressed    healthcare    propensity    adults    introduction    patient    biomarker    market    hyporeactivity    device   

Project "EDOR BOX" data sheet

The following table provides information about the project.

Coordinator		 EMOTRA AB 

Organization address
address: GOTEBORGSVAGEN 74
city: SAVEDALEN
postcode: 433 63
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Sweden [SE]
 Project website http://emotra.se/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-03-01   to  2016-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EMOTRA AB SE (SAVEDALEN) coordinator 50˙000.00

Map

 Project objective

According to the World Health Organization there are 800,000 suicides and 10 million attempts yearly. Appallingly, suicide is the third cause of death among 15-44 years and the second in 15-29 years old. Suicide is a major burden to society emotionally, but also economically. Costs incurred by each attempt rise to €100,000. Half reduction in the number of attempts would save €20 billion to the EU alone. Depression is the disorder most commonly attributed to suicide affecting 350 M people. Antidepressants are commonly prescribed, but they prove to be insufficient if the patient is at risk of committing suicide. However, there are no reliable tests so far to distinguish depressed patients not-at-risk, from those actually at-risk of committing suicide. In response, the Swedish company EMOTRA has developed EDOR-BOX, an innovative biomarker-based device for early detection of suicide risk. Our technology analyzes brain reactivity expressed as sweat impulses when exposed to audio signals. Absent brain responses are reflected in electrodermal hyporeactivity (no electrodermal responses), which we use as a biomarker for suicide risk in depressed patients. EDOR's main objective is to market a unique tool for effective diagnosis of suicide risk in patients from all age groups. We have already demonstrated the safety and efficacy of our device in adults, with 97% sensitivity in clinical trials. Now we aim to ensure its applicability in youngsters, due to the alarming suicide rates in this population. Our method is a cost-effective solution to prevent suicide by ensuring early detection of the risk. EDOR-BOX will provide estimated revenues of €17 M five years upon introduction, with a global impact and the creation of 50 new jobs. Ultimately, EDOR-BOX will overcome the limitations in our healthcare due to the lack of non-subjective diagnostic tools to detect an early onset of suicide propensity, as well as the economic burden coming from non-detected suicidal cases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EDOR BOX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EDOR BOX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More